IRadimed Corporation (NASDAQ:IRMD) Q3 2022 Earnings Conference Call November 3, 2022 11:00 AM ET
Company Participants
Roger Susi - President and Chief Executive Officer
Jack Glenn - Chief Financial Officer
Conference Call Participants
Operator
Welcome to the IRadimed Corporation Third Quarter 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. And at the end of the call, we will conduct a question-and-answer session. As a reminder, this call is being recorded today, November 3, 2022 and contains time-sensitive information that is accurate only as of today. Earlier, IRadimed released its financial results for the third quarter of 2022. A copy of this press release announcing the company's earnings is available under the heading news on their website at iradimed.com.
A press release copy was also furnished to the Securities and Exchange Commission on Form 8-K and can be found at sec.gov.
This call is being broadcast live over the Internet on the company's website at iradimed.com and a replay of the call will be available on the website for the next 90 days. Some of the information in today's session will constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are those focused on the future performance results, plans, and events and may include the company's expected future results. IRadimed reminds you that future results may differ materially from these forward-looking statements due to several risk factors. For a description of the relevant risks and uncertainties that may affect the company's business, please see the risk factors section of the company's most recent reports filed with the Securities and Exchange Commission, which may be obtained for free from the SEC’s website at sec.gov.
I would now like to turn the call over to Roger Susi, President and Chief Executive Officer of Iradimed Corporation. Mr. Susi, please go ahead.
Roger Susi
Thank you operator. Good morning. And thank you for joining us on the call everyone. Today I am again having the pleasant task of reporting that Iradimed has had yet another excellent quarter of revenue and earnings growth as we reported in this morning's release. Q3, 2022 has been our top revenue quarter ever and the third in a string of our strongest growth quarters. Further, I'll interject here that the strong growing demand for our products remains intact, which gives us confidence in the coming quarters that we will also and gives you much more to be proud of there in the future.